Diosmin for Treatment of Delayed-onset Muscle Soreness (DOMS)

Launched by SERGIO MARQUES BORGHI · Nov 7, 2023

Keywords

ClinConnect Summary

This clinical trial is studying the effects of a natural substance called Diosmin on a condition known as delayed-onset muscle soreness (DOMS), which is the muscle pain that often occurs after intense exercise. The goal is to see if Diosmin can help reduce this soreness and make it easier for people to stick with their exercise routines, which is important for maintaining good health and managing chronic pain conditions. This study is particularly focused on adult women aged 58 to 127 years who are capable of doing a specific exercise program.

If you’re interested in participating, you would need to meet certain criteria, like being within the specified age range and being able to engage in a dynamic exercise routine. However, those with any movement disorders or who are currently taking pain-relief medications cannot take part. Participants can expect to engage in exercise while receiving Diosmin, and their muscle soreness will be monitored to see if the treatment helps. This trial is currently looking for volunteers, so it could be a unique opportunity to contribute to research that might help many people manage their muscle soreness better.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Be within the pre-determined age range.
• • Be able to perform the proposed intense dynamic exercise protocol.
• Exclusion Criteria:
• • Locomotor system dysfunctions.
• • Use of analgesic/anti-inflammatory medication at the time of recruitment.
• • Calorie-restricted diet or ergogenic supplementation.